Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion

PURPOSE: We evaluated the relationship between dosing frequency of intravitreal antivascular endothelial growth factor (anti-VEGF) agents and visual acuity (VA) outcomes over 2 years in eyes with macular edema (ME) secondary to central retinal vein occlusion (CRVO) in the US routine clinical practic...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Yasha S., Goduni, Lediana, Moini, Hadi, Gibson, Andrea, Boucher, Nick, Lucas, Genevieve, Dhoot, Dilsher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Manuscripts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976151/
https://www.ncbi.nlm.nih.gov/pubmed/37007170
http://dx.doi.org/10.1177/2474126421989225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976151/
https://www.ncbi.nlm.nih.gov/pubmed/37007170
http://dx.doi.org/10.1177/2474126421989225

Ejemplares similares